These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 23207625

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Gallbladder mass with a carbohydrate antigen 19-9 level in the thousands: malignant or benign pathology? Report of a case.
    Clarke T, Matsuoka L, Jabbour N, Mateo R, Genyk Y, Selby R, Gagandeep S.
    Surg Today; 2007; 37(4):342-4. PubMed ID: 17387571
    [Abstract] [Full Text] [Related]

  • 23. [Tumor markers for pancreatic and biliary tract cancer].
    Takezako Y, Okusaka T, Ueno H, Ikeda M, Morizane C, Najima M.
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
    [Abstract] [Full Text] [Related]

  • 24. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis.
    Lindberg B, Arnelo U, Bergquist A, Thörne A, Hjerpe A, Granqvist S, Hansson LO, Tribukait B, Persson B, Broomé U.
    Endoscopy; 2002 Nov; 34(11):909-16. PubMed ID: 12430077
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Effect of biliary obstruction and cholangitis on serum SPan-1 level].
    Matsumoto S, Muranaka T, Hanada K, Matsuura Y, Oshiumi Y.
    Kaku Igaku; 1990 Dec; 27(12):1443-6. PubMed ID: 2290216
    [Abstract] [Full Text] [Related]

  • 27. Significance of fluorodeoxyglucose PET imaging in the diagnosis of malignancies in patients with biliary stricture.
    Wakabayashi H, Akamoto S, Yachida S, Okano K, Izuishi K, Nishiyama Y, Maeta H.
    Eur J Surg Oncol; 2005 Dec; 31(10):1175-9. PubMed ID: 16019182
    [Abstract] [Full Text] [Related]

  • 28. Extremely elevated CA19-9 in acute cholangitis.
    Sheen-Chen SM, Sun CK, Liu YW, Eng HL, Ko SF, Kuo CH.
    Dig Dis Sci; 2007 Nov; 52(11):3140-2. PubMed ID: 17404889
    [Abstract] [Full Text] [Related]

  • 29. Atypical courses of serum tumor markers--4 case reports.
    Klapdor R, Bahlo M, Babinski A.
    Anticancer Res; 2003 Nov; 23(2A):845-50. PubMed ID: 12820311
    [Abstract] [Full Text] [Related]

  • 30. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.
    Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ.
    Am J Gastroenterol; 2000 Jan; 95(1):204-7. PubMed ID: 10638584
    [Abstract] [Full Text] [Related]

  • 31. Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy.
    Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttilä I, Alhava E.
    Anticancer Res; 1995 Jan; 15(6B):2731-7. PubMed ID: 8669855
    [Abstract] [Full Text] [Related]

  • 32. Double cancer of gall bladder and bile duct not associated with anomalous junction of the pancreaticobiliary duct system.
    Hori H, Ajiki T, Fujita T, Okazaki T, Suzuki Y, Kuroda Y, Fujimori T.
    Jpn J Clin Oncol; 2006 Oct; 36(10):638-42. PubMed ID: 16908513
    [Abstract] [Full Text] [Related]

  • 33. Biliary dysplasia in patients with primary sclerosing cholangitis: additional value of DNA ploidity.
    Halme L, Arola J, Numminen K, Krogerus L, Mäkisalo H, Färkkilä M.
    Liver Int; 2012 May; 32(5):783-9. PubMed ID: 22098817
    [Abstract] [Full Text] [Related]

  • 34. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ, de Bruijn HW, Hollema H, ten Hoor KA, Willemse PH, Aalders JG, van der Zee AG.
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [Abstract] [Full Text] [Related]

  • 35. [Laboratory diagnosis of tumors of the pancreato-biliary area in patients with mechanical jaundice].
    Skvortsov SV, Lytsar' BN, Kalinin AV, Dolinskiĭ AG.
    Klin Med (Mosk); 1992 Jul; 70(5-6):21-3. PubMed ID: 1279265
    [Abstract] [Full Text] [Related]

  • 36. Elevation of CA 19-9 in giant hydronephrosis induced by a renal calculus.
    Meyer A, Kausch I, Krüger S, Fetscher S, Böhle A, Jocham D.
    Urology; 2004 Feb; 63(2):381-2. PubMed ID: 14972505
    [Abstract] [Full Text] [Related]

  • 37. CA 19-9 to rule out pancreatic or biliary cancer among patients with cholestasis: an unsuitable test?
    Madonia S, Aragona E, Maisano S, Montalbano L, Olivo M, Rossi F, Restivo G, Cottone M.
    Dig Dis Sci; 2007 Apr; 52(4):1125-7. PubMed ID: 17342388
    [No Abstract] [Full Text] [Related]

  • 38. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?
    Akdoğan M, Parlak E, Kayhan B, Balk M, Saydam G, Sahin B.
    Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062
    [Abstract] [Full Text] [Related]

  • 39. Eosinophilic cholangitis and wirsungitis as cause of simultaneous bile duct obstruction and pancreatitis.
    Kroemer A, Sabet-Baktach M, Doenecke A, Ruemmele P, Scherer MN, Schlitt HJ, Breidert M.
    Z Gastroenterol; 2012 Aug; 50(8):766-70. PubMed ID: 22895905
    [Abstract] [Full Text] [Related]

  • 40. Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix.
    Carmignani CP, Hampton R, Sugarbaker CE, Chang D, Sugarbaker PH.
    J Surg Oncol; 2004 Sep 15; 87(4):162-6. PubMed ID: 15334630
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.